|
Emergency Notice
People in the path of Hurricane Helene may need help continuing their cancer care.
The National Cancer Institute’s (NCI) Cancer Information Specialists can refer people who have been displaced to nearby cancer centers or NCI Community Oncology Research Program (NCORP) sites to continue their care.
To reach the Cancer Information Service (CIS):
- Call 1-800-4-CANCER (1-800-422-6237)
Monday through Friday from 9:00 a.m. to 9:00 p.m. Eastern Time in English or Spanish. After business hours, recorded information is available.
The CIS LiveHelp program offers online assistance in English and Spanish, Monday through Friday from 9:00 a.m. to 9:00 p.m. Eastern Time.
Visit the Emergency Resources for the Cancer Community.
|
|
Lung Cancer Screening in G7 Cancer Countries: Challenges and Lessons Learned
Thursday, October 10
8:00-9:30 a.m. ET
Advance registration required
In this webinar, G7 cancer organizations across the world will share advances and challenges in lung cancer screening strategies. Jessica Faupel-Badger, Ph.D., of the Division of Cancer Prevention (DCP), is a co-lead of the prevention working group organizing this webinar. G7 Cancer international cooperative brings together the most advanced countries in the fight against cancer.
Learn more about G7 cancer organizations, working groups, and events.
The 3rd Biennial Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Meeting
|
Monday, October 28- Wednesday, October 30
Advance registration required
The TACPAD meeting aims to foster the exchange of ideas and create collaborative interactions among leading cancer prevention researchers, highlight trends in immunoprevention and chemoprevention, and inform the research community about prevention resources available from NCI.
Learn more about TACPAD.
|
|
|
NCORP Recognizes Staff with 2024 Awards
The National Cancer Institute’s (NCI) Community Oncology Research Program (NCORP) selected Judith Hopkins, M.D., and Kristina Gardner, M.H.A., as recipients of this year’s Harry Hynes and Dorothy Coleman Awards, respectively, at the 2024 NCORP annual meeting in Bethesda, Maryland. NCI’s Marge Good, R.N., M.P.H., received an NCORP Special Appreciation Award.
Read more.
|
Looking Deep into Genetic Changes that Increase Colorectal Cancer Risk to Prevent or Detect Inherited Cancers
|
The latest Cancer Prevention Science blog highlights two studies that looked at how genetic changes might be used to find ways to prevent cancers in those with Lynch syndrome either by vaccine or by monitoring without frequent colonoscopies.
Read the Cancer Prevention Science Blog.
|
|
 |
Accelerating Progress to Reduce the Cancer Burden through Prevention and Control in the US
Written by DCP’s Philip Castle, Ph.D., M.P.H., and Asad Umar, D.V.M., Ph.D., and NCI Division of Cancer Control and Population Sciences' Katrina Goddard, Ph.D., and Eric Feuer, Ph.D., the article estimates the potential number of deaths averted and years of life gained by cancer control and prevention efforts in the United States through 2045.
Read the paper.
|
Lexicon for Blood-based Early Detection and Screening: BLOODPAC Consensus Document
The Early Detection & Screening Working Group of the Blood Profiling Atlas in Cancer (BLOODPAC) Consortium standardized definitions for 14 key terms and concepts relevant to the development of non-invasive single- and multi-cancer detection tests. DCP’s Wendy Rubinstein, M.D., Ph.D., is a co-author.
Read the paper.
|
|
|
Notice of Funding Opportunities (NOFOs): Cancer Health Disparities and Immunoprevention Network |
|
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting innovative basic, mechanistic research on the biological and genetic causes of cancer health disparities, including those related to basic research in cancer biology or cancer prevention strategies.
Expires: November 6, 2024
PAR-24-277
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
This NOFO encourages grant applications from investigators interested in conducting basic research on the biological and genetic causes and mechanisms of cancer health disparities.
PAR-24-291
Expires: November 17, 2024
Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed)
Through this NOFO, NCI intends to establish a Cancer Immunoprevention Network (CIP-Net) Data and Resource Coordinating Center (CIP-Net DRCC). The overall goal of this NOFO to establish an agile and effective network to collaborate on cancer immunoprevention research.
RFA-CA-24-036
Expires: December 3, 2024
|
|
|
NCI PREVENT Cancer Program – Research Support Opportunity in Cancer Prevention & Interception
The NCI PREVENT Cancer Preclinical Drug Development Program (PREVENT) is accepting applications to support the preclinical development of innovative interventions and predictive biomarkers for cancer prevention and interception towards clinical applications in high-risk populations. Interested researchers from academia, industry, non-profits, and government with innovative ideas in precision cancer prevention are encouraged to apply.
Deadline: Monday, November 4, 2024.
For more information on Program support, types of supported projects, and the application visit the PREVENT web page.
Recording Available: Interventions for Cancer-related Cognitive Impairment
Missed the last Building Bridges in Cancer Symptom Science Webinar?
Watch the recording.
|
In case you missed it:
Read more DCP Updates.
Do you forward DCP Updates to others?
Encourage them to subscribe.
|
|
|
|
|
